ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
13.29
-0.15 (-1.12%)
At close: May 12, 2025, 4:00 PM
14.00
+0.71 (5.34%)
After-hours: May 12, 2025, 7:28 PM EDT
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $1.31 billion as of May 12, 2025. Its market cap has increased by 63.75% in one year.
Market Cap
1.31B
Enterprise Value
1.06B
1-Year Change
63.75%
Ranking
Category
Stock Price
$13.29
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $1.31B, an increase of 129.69%. That is a compound annual growth rate of 39.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 1.32B | 28.74% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |